Connect with us

News

What are the different types of CBD oil available in the UK?

Leading CBD brand Bud & Tender explain the different types of CBD oil available on the UK market.

Published

on

We sat down with Bud & Tender to speak to them about the different types of CBD oil available on the market and to learn why their premium CBD oil has been voted as the best in the UK.

Before we dive into the different types of CBD oil, we asked Bud & Tender what recognition have they received for their premium CBD oil so far?

It’s been an amazing journey so far for us here at Bud & Tender and we have managed to achieve a lot of firsts.

We are the first and only UK CBD company to have our oil approved by the Medical Cannabis Clinicians Society. This essentially means our CBD oil is recommended by doctors.

We have been voted as the best CBD oil by multiple industry review websites. In fact, we have won the best THC-free CBD oil and best overall CBD oil.

We are the first company in the UK to test our oil’s cannabinoid potency to a limit of quantification of 0.001 per cent. This is very important because it offers our customers very accurate dosing in terms of what they are actually consuming.

We are the first company in the UK to conduct full panel lab testing (ISO17025 certified) on our oil to ensure it is clean and safe to consume. This means our CBD oil is free from heavy metals, pesticides, Microbiologicals, residual solvents and Mycotoxins.

Last but not least, we are the first and currently the only CBD oil to be recommended to UKCSC patients.

bud & tender: a bottle of CBD oil

What makes Bud &Tender CBD oil so different to the rest of the market?

Firstly, our product is not a white-label product. What you need to understand is that most CBD oils on the market today are just mass-produced white label products from the same manufacturer. This means a lot of oils on the market are the same.

We manufacture our own oil in our own unique way with the use of co2 and ethanol. Our goal has always been to preserve as much of the plant active compounds as possible while removing any controlled substances and waste material.

READ MORE  Combining CBD and CBG for the ultimate entourage effect

Our product doesn’t have a bitter taste like most CBD oils, it tastes fresh with a fruity floral cannabis undertone. We haven’t added any artificial flavours or additives, our oil is 100% natural

Bud & Tender premium CBD oil contains a powerful broad-spectrum profile that consists of CBD, CBG, CBDV, CBC and CBT making it much more effective than just CBD alone.

What are the different types of CBD oil on the market?

Great question and something not a lot of people are aware of. CBD oils can be divided into multiple categories: Whole-plant, Full Spectrum, Broad-Spectrum, Narrow Spectrum and No-Spectrum.

Whole-Plant

Whole-plant (crude) CBD oil uses an unrefined CBD extract. It contains the key compounds from the cannabis flower such as cannabinoids, terpenes and flavonoids, plus undesirable compounds such as fats, lipids, waxes and chlorophyll.

The undesirable compounds are considered contaminants in CBD extracts. The more undesirable compounds present in an extract, the lower the quality of the CBD oil.

Whole-plant benefits from the entourage effect and will contain controlled cannabinoids such as THC, CBN or THCV. If the combined total amount of the controlled cannabinoids is over 1mg per container, the product is classed as a Schedule 1 drug under the MDR 2001 and illegal in the UK. Users can fail a controlled drug test.

Full-Spectrum

Full-spectrum CBD oil uses a refined CBD extract. The key compounds of cannabinoids and terpenes will be present along with some flavonoids. The undesirable compounds of fats, lipids, waxes and chlorophyll have been removed resulting in a high-quality CBD oil.

Full-Spectrum CBD oil does benefit from the entourage effect.

By definition, it will contain controlled cannabinoids such as THC, CBN or THCV. If the combined total amount of controlled cannabinoids is over 1mg per container the product is classed as a Schedule 1 drug under the MDR 2001 and illegal in the UK. Users can fail a controlled drug test.

Broad-Spectrum

Broad-spectrum CBD oil uses a further refined CBD extract. The key compounds of cannabinoids and terpenes will be present along with trace amounts of flavonoids. The undesirable compounds of fats, lipids, waxes and chlorophyll have been removed.
Controlled cannabinoids such as THC, CBN and THCV have also been removed, classifying it as a legal, high-quality CBD Oil.
Broad-spectrum CBD oil does benefit from the entourage effect.

READ MORE  How to practice winter wellness using CBD skincare

It does not contain controlled cannabinoids like THC, CBN or THCV. It is not classed as a schedule 1 drug and may be sold as a food supplement. Users will pass a controlled drug test.

Narrow-Spectrum

Narrow-spectrum CBD oil uses an over refined CBD extract. The number of cannabinoids and terpenes present has been significantly reduced through over-refinement. The undesirable compounds of fats, lipids, waxes and chlorophyll have been removed along with controlled cannabinoids such as THC, CBN and THCV.

It does not fully benefit from the entourage effect. The over-refinement results in a loss of minor cannabinoids and terpenes which reduces the entourage effect. It does not contain controlled cannabinoids like THC, CBN or THCV. It is not classed as a schedule 1 drug and may be sold as a food supplement. Users will pass a controlled drug test.

No-Spectrum

No-spectrum CBD oil uses a CBD isolate extract. There is only CBD present, the isolated extract is usually 99 per cent pure CBD. There are no additional cannabinoids, there are no terpenes or flavonoids. It does not benefit from the entourage effect and the effectiveness is biphasic; once hitting optimal dosage, effects begin to reverse or diminish even when dosages are increased.
It’s just isolated CBD, it does not contain controlled cannabinoids like THC, CBN or THCV. It is not classed as a schedule 1 drug and may be sold as a food supplement. Users will pass a controlled drug test.

Conclusion

Whole-Plant and Full-Spectrum oils by definition contain controlled drugs and if they contain a combined value of over 1mg in controlled cannabinoids they are classed as a Schedule 1 drug under the MDR 2001, sadly making them illegal.

Broad-Spectrum, Narrow-Spectrum and No-Spectrum CBD oils have had the controlled cannabinoids removed and can be sold as food supplements.

READ MORE  How wellness brand Papilio is helping people live a calmer and happier life

If you are looking for the most effective legal CBD oil; Broad-Spectrum is your best bet. However, you need to be careful as some companies claim Broad-Spectrum when in reality, their products are Narrow-Spectrum.

Bud & Tender premium CBD oil is an award-winning true Broad-Spectrum oil.

Do you think THC and other controlled cannabinoids should be allowed in CBD supplements?

Yes, we think so. THC along with the other controlled cannabinoids have fantastic properties that work in different ways to CBD in the body. THC is available with a medical prescription in the UK, but we’d like to see it more readily available over the counter. The ideal would be similar to the Swiss model where 1 per cent THC is allowed in CBD supplements.

Bud & Tender: A woman sampling a CBD oil

Can I try Bud & Tender CBD oil for free?

Yes! We offer 1ml samples of our premium CBD oil for people to try before they buy. You can try our 10 per cent CBD oil (1ml sample) for free by using code: CHFREE

CHFREE will reduce the price of the sample from £10 to £0. Please note p&p is £3.50. Visit bud&Tender.com

Is there a discount code for your full-size products?

Yes, for a 15 per cent discount off any 10ml or 30ml bottle use code: CH15

Any tips when trying your CBD oil for the first time?

Yes, make sure to hold the oil under your tongue for as long as possible. We say a minimum of three minutes, however the longer you hold the oil under your tongue the better the chance the CBD has of being absorbed into your oral mucosa.

What’s next for Bud & Tender?

We have been investing a lot of time and energy into research and our product development is well underway. We’ll be releasing some new products this year and hopefully achieving some firsts with those too.

If you have any questions or wish to speak with Bud & Tender you can contact them via email at info@budandtender.com or via telephone on 0208 144 0099.

Bud & Tender: A banner stating this is collaborative content

News

New studies examine effects of THC and CBD on stroke

New data suggests both positive and negative effects of cannabis in stroke patients

Published

on

A new study has shown that pre-treatment CBD may have a neuroprotective effect in stroke patients.

The study aimed to investigate the effect of CBD on oxidative stress and cell death which occurs in ischemic stroke patients.

It revealed that the cannabinoid may reduce the destructive effects of cell damage associated with stroke.

Ischemic strokes are the most common type of stroke. They occur when a blood clot blocks a flow of oxygen or blood to the brain. This takes place in arteries that have been narrowed or blocked over time by fatty deposits (plaques). The most common symptoms of a stroke include facial drooping on one side, not being able to lift your arms and slurred speech.

If this occurs, it is vital that a person be taken to the emergency room immediately.

The National Institute of Health Care and Excellence (NICE) estimate that there are around 100,000 strokes every year in the UK. It is also thought that 1.3 million people live with the effects of a stroke.

Stroke recovery and CBD results

The Study showed that CBD reduced the amount of infarction in those samples which had been given the cannabinoid. Infarction refers to the death of tissue as a result of a lack of blood supply and is commonly due to a blood vessel being obstructed or narrowed.

There were also differences in malondialdehyde level (MDA) – a common marker of oxidative stress – between the brains of the CBD group and the vehicle group.

It also revealed that CBD may help to protect tissue by preventing further damage.

READ MORE  JuicyFields cannabis crowd growing movement challenges Canadian “green rush”

THC and stroke risk

Another recent study examined the effect that tetrahydrocannabinol (THC) could have on strokes. It found that it may increase the risk of a certain type of stroke among cannabis consumers.

According to findings, cannabis consumers who experience a stroke known as an aneurysmal subarachnoid haemorrhage (aSAH), are twice as likely to develop further complications.

An aSAH occurs when a weakened blood vessel bursts on the surface of the brain leading to bleeding between the brain and tissue that covers it. It can result in neurological disabilities, long-term slurred speech or even death. It is estimated that aSAH affects around eight people per 100,000 of the population each year, accounting for six per cent of first strokes.

The study by the American Stroke Association suggested there is twice the risk of developing delayed cerebral ischemia for cannabis consumers. The researchers analysed data from 1,000 patients who had received treatment for bleeding over a 12 year period. In the group of participants, 36 per cent developed cerebral ischemia and 50 per cent had moderate to severe disabilities.

When comparing the results of patients who tested positive for THC with those who did not, they found cannabis consumers were 2.7 times more likely to develop cerebral ischemia. They were also 2.8 times more likely to develop long-term moderate to severe physical disabilities.

However, compared to those who tested negative for THC, the cannabis group did not have larger aneurysms, higher blood pressures or worse stroke symptoms when admitted to the hospital. They did not have any higher cardiovascular risk factors than the negative group.

READ MORE  How to practice winter wellness using CBD skincare

Researchers are now conducting further studies in which they hope to better understand if THC can impact aneurysm formation and rupture.

Stroke: A banner advert for cannabis health news sign ups

Continue Reading

News

New study shows CBD may prevent Covid-19 infection

Researchers are calling for more trials to determine if CBD could be a preventative or early treatment for the virus.

Published

on

Covid: A covid infection

Researchers are recommending clinical trials to examine if CBD could help to prevent Covid infection after more positive findings have been published.

Researchers from the University of Chicago have reported that CBD may stop the infection of Covid-19 by blocking its ability to replicate in the lungs.

A number of cannabinoids including CBD and THC were tested along with 7-Hydroxycannabidiol (7-OH-CBD) which is thought to be produced when cannabidiol is processed by the body.

The study found that CBD showed a significant negative association with SARS-CoV-2 positive tests in a national sample of patients who were taking  high doses of CBD, prescribed for epilepsy.

As a result of their findings, researchers are calling for more clinical trials to determine whether CBD could eventually be used as a preventative or early treatment for the virus.

Covid- Covid infection

Covid and CBD study

Researchers treated human lung cells with a non-toxic dose of CBD for two hours before exposing the cells to SARS-CoV-2 and monitoring them for the virus and the viral spike protein.

They found that, above a certain threshold concentration, CBD inhibited the virus’ ability to replicate.

Further investigation found that CBD had the same effect in two other types of cells and for three variants of SARS-CoV-2 in addition to the original strain.

CBD did not affect the ability of SARS-CoV-2 to enter the cell. Instead, CBD was effective at blocking replication early in the infection cycle and six hours after the virus had already infected the cell.

Like all viruses, SARS-CoV-2 affects the host cell by hijacking its gene expression machinery to produce more copies of itself and its viral proteins. This effect can be observed by tracking virus-induced changes in cellular RNAs. High concentrations of CBD almost completely eradicated the expression of viral RNAs.

READ MORE  'I was a shadow of a person, then medical cannabis changed my life'

When it came to the other cannabinoids, CBD was found to be the only potentially potent agent. There was no or limited antiviral activity noted by the similar cannabinoids including THC, CBDA, CBDV, CBC or even CBG.

Marsha Rosner, PhD, professor and senior author of the study said it was a completely unexpected result, she commented: “CBD has anti-inflammatory effects, so we thought that maybe it would stop the second phase of COVID infection involving the immune system, the so-called ‘cytokine storm.’ Surprisingly, it directly inhibited viral replication in lung cells.

She added: “We just wanted to know if CBD would affect the immune system. No one in their right mind would have ever thought that it blocked viral replication, but that’s what it did.”

The researchers do caution that this is not possible with commercially available CBD. The CBD tested was high-purity and also medical grade.

However, Rosner cautioned:  “Going to your corner bakery and buying some CBD muffins or gummy bears probably won’t do anything. The commercially available CBD powder we looked at, which was off the shelf and something you could order online, was sometimes surprisingly of high purity but also of inconsistent quality. It is also hard to get into an oral solution that can be absorbed without the special, FDA-approved formulation.”

CBD and Covid studies

This is the second study to be released showing the potential for cannabinoids in Covid management and prevention.

A study by Oregon State University has revealed that the compounds cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA), may have the ability to prevent the virus that causes Covid-19 from entering human cells.

READ MORE  How wellness brand Papilio is helping people live a calmer and happier life

Researchers and scientists, led by Richard van Breedan, found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, blocking a step in the process the virus takes for infection.

Targeting compounds that block the virus-receptor interaction has been helpful for patients with other viral infections such as HIV-1 and hepatitis.

The researchers and scientists identified the two cannabinoid acids through a screening technique, developed previously in van Breeman’s laboratory. The team also screened different botanicals such as red clover, hops, wild yam and three types of liquorice.

Continue Reading

News

Partner of Irish politician “six years seizure free” faces charges over medical cannabis use

John Montaine uses medical cannabis to manage his epilepsy – and is said to be six years seizure free.

Published

on

Irish government medical cannabis
John Montaine, is the partner of Clare Sinn Fein TD Violet Ann Wynne.

The partner of a sitting Irish TD is contesting charges of cannabis possession, saying he uses it medicinally to manage his epilepsy.

John Montaine, who is the partner of Clare Sinn Fein TD Violet Ann Wynne, was charged with the alleged illegal possession of cannabis on February 11, 2021, at his family home, the Irish Independent reported.

Mr Montaine contests the charges and his partner Deputy Wynne has previously spoken publicly about how he uses cannabis medicinally to manage his epilepsy.

Speaking after the initial court hearing in November, Deputy Wynne said in March her partner would be “six years seizure free”.

She went on to say that it has improved his quality of life “100 per cent, without a doubt”.

“There was always some kind of issue – say John having a number of fits within the one month or losing teeth or suffering with severe migraine, but since John has been using the medicinal cannabis, he has had a better quality of life,” Deputy Wynne told the Independent.

She added: “It has also freed myself up. John would have been on disability allowance and I would have had to have been his carer but since using the medicinal cannabis, he doesn’t suffer from any of those issues any longer.”

Medical cannabis is legal in Ireland, but access to a prescription is limited.

Last year Ryan Gorman, a 26-year-old man, from Dublin, who also suffers from epilepsy, became the first patient to receive a cannabis-based medicine through the Medical Cannabis Access Programme.

Despite legislation being signed off in 2019, Ireland’s Health minister Stephen Donnelly only announced funding for it in January 2021, with the programme only becoming fully operational in November.

Four cannabis-based medicines are expected to be available through the MCAP, to people living with one of three qualifying conditions. These include intractable nausea and vomiting associated with chemotherapy, severe treatment-resistant epilepsy and spasticity associated with multiple sclerosis (MS). 

Mr Montaine’s solicitor appeared in Kilrush District Court on behalf of his client this week, where his case was adjourned until 15 March.

READ MORE  JuicyFields aims to be one of the top five producers of medical cannabis by 2025
Continue Reading

Trending